ARD-101, a gut-restricted TAS2R agonist, reduces hunger in adults and promotes weight loss in DIO mice with DPP-4 inhibition

Authors

Institutions

Publication Details

Journal
Molecular Metabolism
Published
2026-03-14
DOI
https://doi.org/10.1016/j.molmet.2026.102340
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ARD-101, a gut-restricted TAS2R agonist, reduces hunger in adults and promotes weight loss in DIO mice with DPP-4 inhibition

Bryan W. Jones, Timothy J. Kieffer, Brad Hirakawa, Justin T. Stege et al.
Molecular Metabolism
Diabetes Treatment and Management
article

ARD-101, a gut-restricted TAS2R agonist, reduces hunger in adults and promotes weight loss in DIO mice with DPP-4 inhibition

Bryan W. Jones, Timothy J. Kieffer, Brad Hirakawa, Justin T. Stege, Jerlyn Tolentino, Zhenhuan Zheng, Jeremy H. Pettus, Manasi Jaiman, Tien-Li Lee, Alexa Warner, Megan Pugsley
article en

Abstract

No abstract available for this paper.
Molecular MetabolismVol. 106
University of British Columbia (CA), University of California San Diego Medical Center (US), Museum of Contemporary Art San Diego (US)
Zero hunger
Openalex Percentile: Top 24%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.